haloperidol has been researched along with Cerebral Palsy in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report describes a 15-year-old male patient with spastic diplegic cerebral palsy, Gross Motor Function Classification System Level III, who developed severe new cognitive and motoric impairments after the administration of haloperidol." | 7.79 | Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. ( Gelfius, CD; Mortimer, D; Potts, MA, 2013) |
| "A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine." | 7.67 | An interaction between haloperidol and carbamazepine in a patient with cerebral palsy. ( Brayley, J; Yellowlees, P, 1987) |
| "This case report describes a 15-year-old male patient with spastic diplegic cerebral palsy, Gross Motor Function Classification System Level III, who developed severe new cognitive and motoric impairments after the administration of haloperidol." | 3.79 | Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. ( Gelfius, CD; Mortimer, D; Potts, MA, 2013) |
| "A 37-year-old woman with cerebral palsy and a rapid cycling bipolar affective disorder developed drowsiness and slurred speech when being treated with a combination of haloperidol and a low dose of carbamazepine." | 3.67 | An interaction between haloperidol and carbamazepine in a patient with cerebral palsy. ( Brayley, J; Yellowlees, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mortimer, D | 1 |
| Gelfius, CD | 1 |
| Potts, MA | 1 |
| Brayley, J | 1 |
| Yellowlees, P | 1 |
2 other studies available for haloperidol and Cerebral Palsy
| Article | Year |
|---|---|
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine | 2013 |
An interaction between haloperidol and carbamazepine in a patient with cerebral palsy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Cerebral Palsy; Diabetes Mellitus, Type 1; Dose-Response Rel | 1987 |